This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Anheuser-Busch Inbev (BUD) Stock Moves -0.16%: What You Should Know
by Zacks Equity Research
In the latest trading session, Anheuser-Busch Inbev (BUD) closed at $57.39, marking a -0.16% move from the previous day.
Anheuser-Busch Inbev (BUD) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Anheuser-Busch Inbev (BUD) closed the most recent trading day at $56.85, moving +1.48% from the previous trading session.
AB InBev (BUD) on Track With Its Growth Efforts: Apt to Hold?
by Zacks Equity Research
Despite cost headwinds, AB InBev's (BUD) rapid expansion of its digital platform, solid demand and continued premiumization bode well.
Anheuser-Busch Inbev (BUD) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Anheuser-Busch Inbev (BUD) closed the most recent trading day at $56.02, moving -0.28% from the previous trading session.
Top Stock Reports for Microsoft, Novo Nordisk & Booking Holdings
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Novo Nordisk A/S (NVO) and Booking Holdings Inc. (BKNG).
Anheuser-Busch Inbev (BUD) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Anheuser-Busch Inbev (BUD) closed the most recent trading day at $56.20, moving +0.3% from the previous trading session.
Anheuser-Busch Inbev (BUD) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Anheuser-Busch Inbev (BUD) closed at $56.18 in the latest trading session, marking a -1.25% move from the prior day.
Time to Get High on Pot Stocks? (3 Catalysts)
by Andrew Rocco
When it comes to marijuana, a significant disconnect exists between the US government and the American people. Stock Strategist Andrew Rocco explains why the worst may be over for marijuana investors.
Anheuser-Busch (BUD) Sells 8 Beer & Beverage Brands to Tilray
by Zacks Equity Research
AB InBev (BUD) enters a deal to sell eight beer and beverage brands to Tilray following its Bud Light controversy.
Company News for Aug 4, 2023
by Zacks Equity Research
Companies In The News Are: WRK, SO, COP, BUD.
AB InBev (BUD) Q2 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
AB InBev's (BUD) Q2 results reflect gains from pricing actions, ongoing premiumization and other revenue-management initiatives amid higher costs.
Factors Likely to Influence AB InBev's (BUD) Q2 Earnings
by Zacks Equity Research
AB InBev (BUD) Q2 results are expected to reflect the benefits of its unique commercial strategy, a strong brand portfolio, and investments in brands and operation excellence.
Zacks Investment Ideas feature highlights: Apple, Adidas and Anheuser-Busch
by Zacks Equity Research
Apple, Adidas and Anheuser-Busch have been highlighted in this Investment Ideas article.
Messi to Miami (3 Stocks to Benefit)
by Andrew Rocco
Soccer is the world's most popular sport. 3 companies are set to benefit from Lionel Messi's move to Miami.
Anheuser-Busch Inbev (BUD) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Anheuser-Busch Inbev (BUD) closed at $58.43, marking a +1.62% move from the previous day.
Anheuser-Busch Inbev (BUD) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Anheuser-Busch Inbev (BUD) closed at $57.60, marking a -1.01% move from the previous day.
FEMSA (FMX) Rises 20% in Six Months: Will the Rally Continue?
by Zacks Equity Research
FEMSA (FMX) looks poised for growth on gains from continued strength in OXXO Mexico and OXXO Gas, expansion into newer businesses and digital initiatives.
Anheuser-Busch Inbev (BUD) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Anheuser-Busch Inbev (BUD) closed at $56.20 in the latest trading session, marking a +1.12% move from the prior day.
Here's Why AB InBev (BUD) Can Make it Big Despite Cost Headwinds
by Zacks Equity Research
AB InBev's (BUD) rapid expansion of its digital platform, leveraging technology, such as B2B sales and other e-commerce platforms, including BEES and Z¿¿ Delivery, bodes well.
The Zacks Analyst Blog Highlights Microsoft, Anheuser-Busch InBev, HCA Healthcare, Delta Air Lines and TELUS
by Zacks Equity Research
Microsoft, Anheuser-Busch InBev, HCA Healthcare, Delta Air Lines and TELUS are included in this Analyst Blog.
Top Research Reports for Microsoft, Anheuser-Busch InBev & HCA Healthcare
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Anheuser-Busch InBev SA/NV (BUD) and HCA Healthcare (HCA).
Digital & Diversification Plans Place FEMSA (FMX) for Growth
by Zacks Equity Research
FEMSA (FMX) looks poised for growth on its diversified business portfolio, growth in the digital business and expansion in the specialized distribution business.
The Zacks Analyst Blog Highlights Meta, Boeing, IBM, Accenture and Anheuser-Busch
by Zacks Equity Research
Meta, Boeing, IBM, Accenture and Anheuser-Busch are part of the Zacks top Analyst Blog.
Can Premiumization & Investments Aid AB InBev's (BUD) Growth?
by Zacks Equity Research
Amid a high-cost environment, AB InBev (BUD) looks poised for growth on relentless execution, investment in its brands and accelerated digital transformation.
Top Stock Reports for Meta Platforms, Boeing & IBM
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), The Boeing Company (BA) and International Business Machines Corporation (IBM).